4D Molecular Therapeutics grants 96,000 inducement RSUs to seven new employees
FDMT•Inducement awards to new employees
4D Molecular Therapeutics granted 96,000 restricted stock units to seven new non-executive employees on Sept. 8, 2026.
The awards were issued under the company’s 2025 Employment Inducement Award Plan, as amended.
